NHI · NYSE
National Health Investors (NHI) Stock Price & Fundamentals
National Health Investors (NHI) closed at $430.99 on Oct 9, 2026, up 0.84% from the previous close of $427.40.
Share price, past year
1Y +41.44%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $430.99 |
| Sep 30, 2026 | $425.34 |
| Aug 31, 2026 | $402.65 |
| Jul 31, 2026 | $417.54 |
| Jun 30, 2026 | $404.78 |
| May 29, 2026 | $382.75 |
| Apr 30, 2026 | $409.60 |
| Mar 31, 2026 | $382.48 |
| Feb 27, 2026 | $345.87 |
| Jan 30, 2026 | $333.86 |
| Dec 31, 2025 | $336.45 |
| Nov 28, 2025 | $342.60 |
| Oct 31, 2025 | $325.19 |
Key statistics
- Market cap
- $20.82B
- P/E (TTM)
- 124.6
- EPS (TTM)
- $3.46
- Revenue (TTM)
- $432.12M
- Net income (TTM)
- $166.80M
- Shares outstanding
- 48.3M
- Dividend yield
- 0.85%
- 52-week range
- $304.72 – $430.99
National Health Investors's market cap is $20.82B, based on a share price of $430.99 and 48.3M shares outstanding as of Jun 30, 2026.
Financials
National Health Investors reported revenue of $375.63M for fiscal 2025, up 12.07% from fiscal 2024.
National Health Investors earned net income of $142.18M in fiscal 2025, a net margin of 37.9%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $375.63M | +12.1% | $142.18M | 37.9% | $3.02 | −$57.47M |
| FY2024ended Dec 31, 2024 | $335.18M | +4.8% | $137.99M | 41.2% | $3.13 | $49.84M |
| FY2023ended Dec 31, 2023 | $319.84M | +15.0% | $135.65M | 42.4% | $3.13 | $134.89M |
| FY2022ended Dec 31, 2022 | $278.19M | −6.9% | $66.40M | 23.9% | $1.48 | $174.35M |
| FY2021ended Dec 31, 2021 | $298.72M | −10.2% | $111.80M | 37.4% | $2.44 | $160.51M |
| FY2020ended Dec 31, 2020 | $332.81M | +4.6% | $185.13M | 55.6% | $4.14 | $115.42M |
| FY2019ended Dec 31, 2019 | $318.08M | +8.0% | $160.46M | 50.5% | $3.67 | $3.77M |
| FY2018ended Dec 31, 2018 | $294.61M | +5.7% | $154.33M | 52.4% | $3.67 | $60.22M |
| FY2017ended Dec 31, 2017 | $278.66M | +12.2% | $159.37M | 57.2% | $3.87 | $22.30M |
| FY2016ended Dec 31, 2016 | $248.46M | — | $151.54M | 61.0% | $3.87 | −$218.10M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $121.32M | $55.67M | $1.15 |
| Q1 FY2026ended Mar 31, 2026 | $115.13M | $40.10M | $0.82 |
| Q4 FY2025ended Dec 31, 2025 | $105.82M | $38.16M | $0.80 |
| Q3 FY2025ended Sep 30, 2025 | $89.85M | $32.86M | $0.69 |
| Q2 FY2025ended Jun 30, 2025 | $90.66M | $36.99M | $0.79 |
| Q1 FY2025ended Mar 31, 2025 | $89.30M | $34.17M | $0.74 |
| Q4 FY2024ended Dec 31, 2024 | $85.75M | $43.24M | $0.96 |
| Q3 FY2024ended Sep 30, 2024 | $82.94M | $28.54M | $0.65 |
Company profile
- Name
- National Health Investors, Inc.
- Ticker
- NHI
- Exchange
- NYSE
- Industry (SEC SIC)
- Real Estate Investment Trusts
- Headquarters
- 222 Robert Rose Drive, Murfreesboro, TN 37129
- Incorporated in
- MD
- Fiscal year ends
- December
- SEC CIK
- 0000877860
Recent SEC filings
- Aug 27, 2026
- Aug 10, 2026
- Aug 10, 2026
- Aug 10, 2026
- Aug 10, 2026
- Jul 27, 2026
- Jul 1, 2026
- Jul 1, 2026
Frequently asked questions
What is National Health Investors's stock price?
National Health Investors (NHI) closed at $430.99 on Oct 9, 2026, up 0.84% from the previous close of $427.40.
What is National Health Investors's market cap?
National Health Investors's market cap is $20.82B, based on a share price of $430.99 and 48.3M shares outstanding as of Jun 30, 2026.
How much revenue does National Health Investors make?
National Health Investors reported revenue of $375.63M for fiscal 2025, up 12.07% from fiscal 2024.
What is NHI's P/E ratio?
National Health Investors's price-to-earnings ratio is 124.6, based on trailing twelve-month diluted EPS of $3.46.
Does National Health Investors pay a dividend?
Yes. National Health Investors declared $3.68 per share in dividends over the last four quarters, a yield of 0.85%.
Sources and methodology
Fundamentals come from National Health Investors, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures